Startseite Technical and clinical validation of the Greiner FC-Mix glycaemia tube
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Technical and clinical validation of the Greiner FC-Mix glycaemia tube

  • Eline A.E. van der Hagen , Marion J. Fokkert , Amanda M.D. Kleefman , Marc H.M. Thelen EMAIL logo , Sjoerd A.A. van den Berg und Robbert J. Slingerland
Veröffentlicht/Copyright: 11. März 2017
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background:

Measurement of adequate glucose concentrations is complicated by in vitro breakdown of glucose due to glycolysis. Unlike the commonly used NaF-EDTA and NaF-oxalate phlebotomy tubes, citrated NaF-EDTA tubes are reported to directly and thereby completely inhibit glycolysis. Recently, Greiner introduced the Vacuette® FC-Mix NaF-EDTA-citrate tube, currently the only NaF-citrate tube without volume-disturbing liquid additions available on the European market. Here we present its potential as alternative for the laborious and therefore unfeasible conditions for glucose sampling as recommended by the World Health Organization (WHO).

Methods:

The FC-Mix tube was tested against the WHO recommended method of optimal laboratory conditions, both in healthy volunteers and pregnant woman undergoing oral glucose tolerance test (oGTT) for screening of gestational diabetes mellitus (GDM). Glucose concentrations were measured after different incubation times (0–48 h) and temperatures (room temperature, 37 °C), both in uncentrifuged whole blood and centrifuged material.

Results:

Deming regression analysis shows that glucose concentrations measured in the FC-Mix tube correlate to the WHO recommended method. Stability is maintained at room temperature for 48 h and at least 24 h at 37 °C. The use of the FC-Mix tube was also validated in screening for GDM and proved comparable to the WHO recommended method in diagnostic outcome.

Conclusions:

The new Greiner FC-Mix tube combines the easy handling of a routine tube with dry additive with the ability to immediately inhibit glycolysis as in the WHO method for optimal pre-analytical and analytical conditions and performs equally to those conditions when screening for GDM.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: The Department of Clinical Chemistry, Isala, Zwolle, received financial support from Greiner BioOne for the conducted research. No financial support was provided for authorship and/or publication of this article.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011;57:e1–e47.10.1373/clinchem.2010.161596Suche in Google Scholar

2. Burtis CA, Ashwood ER, Bruns DE. Tietz textbook of clinical chemistry and molecular diagnostics, 5th ed. St. Louis, USA: Saunders/Elsevier, 2012.Suche in Google Scholar

3. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva, Switzerland: WHO, 2006.Suche in Google Scholar

4. Mikesh LM, Bruns DE. Stabilization of glucose in blood specimens: mechanism of delay in fluoride inhibition of glycolysis. Clin Chem 2008;54:930–2.10.1373/clinchem.2007.102160Suche in Google Scholar

5. Chan AY, Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989;35:315–7.10.1093/clinchem/35.2.315Suche in Google Scholar

6. Uchida K, Matuse R, Toyoda E, Okuda S, Tomita S. A new method of inhibiting glycolysis in blood samples. Clin Chim Acta 1988;172:101–8.10.1016/0009-8981(88)90125-8Suche in Google Scholar

7. Gambino R, Piscitelli J, Ackattupathil TA, Theriault JL, Andrin RD, Sanfilippo ML, et al. Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis. Clin Chem 2009;55:1019–21.10.1373/clinchem.2008.121707Suche in Google Scholar PubMed

8. van den Berg SA, Thelen MH, Salden LP, van Thiel SW, Boonen KJ. It takes acid, rather than ice, to freeze glucose. Sci Rep 2015;5:8875.10.1038/srep08875Suche in Google Scholar PubMed PubMed Central

9. del Pino IG, Constanso I, Mourin LV, Safont CB, Vazquez PR. Citric/citrate buffer: an effective antiglycolytic agent. Clin Chem Lab Med 2013;51:1943–9.10.1515/cclm-2012-0735Suche in Google Scholar PubMed

10. Dimeski G, Yow KS, Brown NN. What is the most suitable blood collection tube for glucose estimation? Ann Clin Biochem 2014;52:270–5.10.1177/0004563214544708Suche in Google Scholar PubMed

11. Daly N, Flynn I, Carroll C, Stapleton M, O’Kelly R, Turner MJ. Comparison of Citrate-fluoride-EDTA with fluoride-EDTA additives to stabilize plasma glucose measurements in women being screened during pregnancy with an oral glucose tolerance test: a prospective observational study. Clin Chem 2016;62:886–7.10.1373/clinchem.2016.254466Suche in Google Scholar PubMed

12. van der Hagen EA, Kleefman AM, Thelen MH, van den Berg SA. Normalisation issues in glucose measurements using phlebotomy tubes with liquid additives. Clin Chem Lab Med 2016;55:e1–e3.10.1515/cclm-2016-0225Suche in Google Scholar PubMed

13. Juricic G, Kopcinovic LM, Saracevic A, Bakliza A, Simundic AM. Liquid citrate acidification introduces significant glucose bias and leads to misclassification of patients with diabetes. Clin Chem Lab Med 2015;54:363–71.10.1515/cclm-2015-0358Suche in Google Scholar

14. Juricic G, Saracevic A, Kopcinovic LM, Bakliza A, Simundic AM. The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive. Clin Biochem 2016;49:1402–5.10.1016/j.clinbiochem.2016.03.006Suche in Google Scholar

15. van den Berg SA, van Thiel SW, Thelen MH. Updating pregnancy diabetes guidelines: is (y)our laboratory ready? Clin Chem Lab Med 2016;54:e225–227.10.1515/cclm-2015-1111Suche in Google Scholar

16. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Int J Gynaecol Obstet 2002;78:69–77.10.1016/S0020-7292(02)00092-9Suche in Google Scholar

17. Daly N, Flynn I, Carroll C, Farren M, McKeating A, Turner MJ. Impact of Implementing Preanalytical Laboratory Standards on the Diagnosis of Gestational Diabetes Mellitus: A Prospective Observational Study. Clin Chem 2016;62:387–91.10.1373/clinchem.2015.247478Suche in Google Scholar PubMed

18. Carlsen S, Petersen PH, Skeie S, Skadberg O, Sandberg S. Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients. Clin Chem Lab Med 2011;49:1501–7.10.1515/CCLM.2011.233Suche in Google Scholar PubMed

19. Ricos C, Alvarez V, Cava F, García-Lario JV, Hernández A, Jiménez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59: 491–500.10.1080/00365519950185229Suche in Google Scholar PubMed

20. Gochman N, Ryan WT, Sterling RE, Widdowson GM. Interlaboratory comparison of enzymatic methods for serum glucose determination. Clin Chem 1975;21:356–61.10.1093/clinchem/21.3.356Suche in Google Scholar

21. Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med 2006;44:311–6.10.1515/CCLM.2006.054Suche in Google Scholar PubMed

22. Winter T, Greiser A, Nauck M, Petersmann A. Long-term stability of glucose: 96-h study using Terumo Glycaemia tubes. Clin Chem Lab Med 2015;54:407–10.10.1515/cclm-2015-0548Suche in Google Scholar PubMed

23. Carey R, Lunt H, Heenan HF, Frampton CM, Florkowski CM. Collection tubes containing citrate stabiliser over-estimate plasma glucose, when compared to other samples undergoing immediate plasma separation. Clin Biochem 2016;49:1406–11.10.1016/j.clinbiochem.2016.05.017Suche in Google Scholar PubMed

24. van den Berg SA, de Groot MJ, Salden LP, Draad PJ, Dijkstra IM, Lunshof S, et al. Pregnancy diabetes: A comparison of diagnostic protocols based on point-of-care, routine and optimized laboratory conditions. Sci Rep 2015;5:16302.10.1038/srep16302Suche in Google Scholar PubMed PubMed Central

25. Yoa RG, Rapin JR, Wiernsperger NF, Martinand A, Belleville I. Demonstration of defective glucose uptake and storage in erythrocytes from non-insulin dependent diabetic patients and effects of metformin. Clin Exp Pharmacol Physiol 1993;20:563–7.10.1111/j.1440-1681.1993.tb01742.xSuche in Google Scholar PubMed

Received: 2016-10-18
Accepted: 2017-1-30
Published Online: 2017-3-11
Published in Print: 2017-8-28

©2017 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorials
  3. Reporting LDL-cholesterol levels in the era of intensive lipid management: a clarion call
  4. The challenges of genetic risk scores for the prediction of coronary heart disease
  5. Reviews
  6. Advanced lipoprotein testing for cardiovascular diseases risk assessment: a review of the novel approaches in lipoprotein profiling
  7. A review of the challenge in measuring and standardizing BCR-ABL1
  8. Mini Review
  9. Challenges in the analysis of epigenetic biomarkers in clinical samples
  10. Opinion Paper
  11. Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “Performance specifications for the extra-analytical phases”
  12. Genetics and Molecular Diagnostics
  13. Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid
  14. General Clinical Chemistry and Laboratory Medicine
  15. A survey of patients’ views from eight European countries of interpretive support from Specialists in Laboratory Medicine
  16. Verification of examination procedures in clinical laboratory for imprecision, trueness and diagnostic accuracy according to ISO 15189:2012: a pragmatic approach
  17. Expressing analytical performance from multi-sample evaluation in laboratory EQA
  18. A candidate reference method for serum potassium measurement by inductively coupled plasma mass spectrometry
  19. Practical motives are prominent in test-ordering in the Emergency Department
  20. Technical and clinical validation of the Greiner FC-Mix glycaemia tube
  21. Comparison of pneumatic tube system with manual transport for routine chemistry, hematology, coagulation and blood gas tests
  22. Accuracy of cerebrospinal fluid Aβ1-42 measurements: evaluation of pre-analytical factors using a novel Elecsys immunosassay
  23. Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry
  24. Analytical performance and diagnostic accuracy of six different faecal calprotectin assays in inflammatory bowel disease
  25. Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases
  26. Hematology and Coagulation
  27. Critical appraisal of discriminant formulas for distinguishing thalassemia from iron deficiency in patients with microcytic anemia
  28. Reference Values and Biological Variations
  29. Reference ranges of thromboelastometry in healthy full-term and pre-term neonates
  30. Cancer Diagnostics
  31. Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression
  32. Cardiovascular Diseases
  33. Assessment of the clinical utility of adding common single nucleotide polymorphism genetic scores to classical risk factor algorithms in coronary heart disease risk prediction in UK men
  34. Time and age dependent decrease of NT-proBNP after septal myectomy in hypertrophic obstructive cardiomyopathy
  35. Infectious Diseases
  36. Higher serum caspase-cleaved cytokeratin-18 levels during the first week of sepsis diagnosis in non-survivor patients
  37. Letters to the Editor
  38. Data mining for age-related TSH reference intervals in adulthood
  39. Intra-laboratory variation and its effect on gestational diabetes diagnosis
  40. Evaluation of long-term imprecision of automated complete blood cell count on the Sysmex XN-9000 system
  41. Sensitivity of the Sysmex XN9000 WPC-channel for detection of monoclonal B-cell populations
  42. Evaluation of biotin interference on immunoassays: new data for troponin I, digoxin, NT-Pro-BNP, and progesterone
  43. Stability of procalcitonin in cerebrospinal fluid
  44. Between-laboratory analysis of IgG antibodies against Aspergillus fumigatus in paired quality control samples
  45. Mass spectrometry vs. immunoassay in clinical and forensic toxicology: qui modus in rebus est?
  46. Great need for changes in higher education in Greece
  47. A note from the Editor in Chief regarding the Letter to the Editor “Great need for changes in higher education in Greece”
Heruntergeladen am 28.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2016-0944/html
Button zum nach oben scrollen